One Preliminary study published on Wednesday (9), the identification of three patients with “deltacrine” in France, Recombination in delta and omicron variants of coronavirus.
However, the research has not yet been published by scientific journals or peer review. In an interview with Reuters, Philip Coulson, of Ihu Méditerranée Infection and lead author of the study, said the specific version of Sars Cov-2 combines the S protein of the omicron and the delta ‘body’.
In addition, according to Reuters, two more infections have been identified in the United States, according to a report not yet published by the gene company Helix. Other surveys have already reported 12 more deltachron infections in European countries since January.
- End of mandatory masks: See the rule in capital cities about indoor and outdoor use
- Corona virus disease: Imaging tests reveal how coronavirus infection can change the brain
Coulson warns that a file Researchers will continue to monitor casesbut it is still too early to determine the transmissibility, influence or influence of a greater or greater extent on the functioning of the virus in humans.
Maria Van Kerkhove, Technical Lead for the World Health Organization (WHO), stated that the recombinants were “expected, especially with the intense omicron and delta rotations”, and that her team was “tracking and discussing” the variant.
It is known that “recombinant events can occur, in humans or animals, with several circulating variants of SARS-CoV-2,” said Somya Swaminathan, chief scientist at the World Health Organization.
“We have to wait for experiments to determine the characteristics of this virus. The importance of sequencing, analysis and rapid data sharing when dealing with this epidemic,” he explained.
“Entrepreneur. Music enthusiast. Lifelong communicator. General coffee aficionado. Internet scholar.”